181 related articles for article (PubMed ID: 35903319)
1. Changes in High-Risk HPV Infection Prevalence and Associated Factors in Selected Rural Areas of China: A Multicenter Population-Based Study.
Yu YQ; Jiang MY; Dang L; Feng RM; Bangura MS; Chen W; Qiao YL
Front Med (Lausanne); 2022; 9():911367. PubMed ID: 35903319
[TBL] [Abstract][Full Text] [Related]
2. Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials.
Zhang Y; Du H; Xiao A; Zhang W; Wang C; Huang X; Qu X; Wang J; Wu R
Infect Agent Cancer; 2022 Jun; 17(1):27. PubMed ID: 35690793
[TBL] [Abstract][Full Text] [Related]
3. Type-specific Distribution of Cervical hrHPV Infection and the Association with Cytological and Histological Results in a Large Population-based Cervical Cancer Screening Program: Baseline and 3-year Longitudinal Data.
Song F; Du H; Xiao A; Wang C; Huang X; Liu Z; Zhao M; Men H; Wu R
J Cancer; 2020; 11(20):6157-6167. PubMed ID: 32922555
[No Abstract] [Full Text] [Related]
4. Independent risk factors for high-risk human papillomavirus infection among rural women in Shanxi Province, China: a population-based, case-control study.
Shi R; Qi W; Cai J; Zhao M; Wang Z
Arch Gynecol Obstet; 2023 Aug; 308(2):551-559. PubMed ID: 36814027
[TBL] [Abstract][Full Text] [Related]
5. [Multi-center cross-sectional study on type-specific human papillomavirus infection among Chinese women].
Zhao Y; Zhao F; Hu S; Chen W; Chen F; Cui J; Liu B; Zhang W; Zhang X; Pan Q; Qiao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1351-6. PubMed ID: 26850387
[TBL] [Abstract][Full Text] [Related]
6. The Risk Factors for Cervical Cytological Abnormalities Among Women Infected With Non-16/18 High-Risk Human Papillomavirus: Cross-sectional Study.
Xiao T; Ou CQ; Yang J; Wang C; Yang M; Yu T; Shen L; Xu X; Xing H
JMIR Public Health Surveill; 2022 Dec; 8(12):e38628. PubMed ID: 36480259
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study.
Hanley SJB; Fujita H; Aoyama-Kikawa S; Kasamo M; Torigoe T; Matsuno Y; Noriaki S;
J Gynecol Oncol; 2021 Nov; 32(6):e86. PubMed ID: 34708593
[TBL] [Abstract][Full Text] [Related]
8. Extensive HPV Genotyping Reveals High Association between Multiple Infections and Cervical Lesions in Chinese Women.
Zhong F; Yu T; Ma X; Wang S; Cong Q; Tao X
Dis Markers; 2022; 2022():8130373. PubMed ID: 35722626
[TBL] [Abstract][Full Text] [Related]
9. High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.
Rijkaart DC; Heideman DA; Coupe VM; Brink AA; Verheijen RH; Skomedal H; Karlsen F; Morland E; Snijders PJ; Meijer CJ
J Clin Microbiol; 2012 Jul; 50(7):2390-6. PubMed ID: 22553244
[TBL] [Abstract][Full Text] [Related]
10. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
[TBL] [Abstract][Full Text] [Related]
11. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
12. HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile.
Lagos M; Van De Wyngard V; Poggi H; Cook P; Viviani P; Barriga MI; Pruyas M; Ferreccio C
Infect Agent Cancer; 2015; 10():43. PubMed ID: 26600869
[TBL] [Abstract][Full Text] [Related]
13. Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China.
Zhao S; Zhao X; Hu S; Lu J; Duan X; Zhang X; Chen F; Zhao F
Chin J Cancer Res; 2019 Aug; 31(4):663-672. PubMed ID: 31564809
[TBL] [Abstract][Full Text] [Related]
14. HPV-based screening for cervical cancer among women 55-59 years of age.
Bergengren L; Lillsunde-Larsson G; Helenius G; Karlsson MG
PLoS One; 2019; 14(6):e0217108. PubMed ID: 31199811
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda.
Nakalembe M; Makanga P; Mubiru F; Swanson M; Martin J; Huchko M
Infect Agent Cancer; 2019; 14():14. PubMed ID: 31114629
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Distribution of HPV Genotypes in 1387 Women with Cervical Intraepithelial Neoplasia 2/3 in Shanxi Province, China.
Wang Z; Li Z; Li J; Wang C; Wang W; Hao M; Zhao C
J Cancer; 2018; 9(16):2802-2806. PubMed ID: 30123348
[No Abstract] [Full Text] [Related]
18. Nationwide Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection in China.
Zeng Z; Austin RM; Wang L; Guo X; Zeng Q; Zheng B; Zhao C
Am J Clin Pathol; 2022 May; 157(5):718-723. PubMed ID: 34724029
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
